ePrescribing Market 2025 Trends and Forecasts 2033: Analyzing Growth Opportunities

Key Insights

The size of the ePrescribing market was valued at USD XXX Billion in 2023 and is projected to reach USD XXX Billion by 2032, with an expected CAGR of 23.9% during the forecast period.ePrescribing will include the electronic transmission of prescription information from providers to pharmacies with the help of EHRs where providers would be able to create and deliver prescriptions directly through the computer of the pharmacy and hence, removing the number of handwritten prescriptions is done and prevents medication errors to its full capacity and improves safety in patients with an efficient and streamlined process for dispensing.ePrescribing has given numerous benefits which include better drug adherence, few prescription frauds, and more accessibility of medicinal information by a patient. It enables effective communication in health care practice and pharmacy whereby they can highlight probable issues around drugs and hence, solve before the problem presents itself.The growth in the ePrescribing market is fueled by government initiatives aimed at encouraging electronic health records adoption, rising healthcare costs, and growing demands for improved patient care and medication safety.

ePrescribing Market Concentration & Characteristics

The ePrescribing market is concentrated in North America and Europe, which accounted for over 60% of the global market in 2023. The market is characterized by a high degree of innovation, with key players constantly investing in new technologies and solutions. Regulatory requirements and product substitutes can impact market growth. End-user concentration is high, with hospitals and office-based physicians being the primary users. M&A activity is also prevalent in the market.

ePrescribing Market Trends

Key market trends include the increasing adoption of Web/cloud-based solutions, the growing use of ePrescribing for controlled substances, and the integration of ePrescribing with other healthcare systems. The use of ePrescribing for oncology, neurology, and cardiology is also growing.

Key Region or Country & Segment to Dominate the Market

North America is expected to continue to dominate the ePrescribing market over the forecast period. The region has a well-established healthcare system and high levels of government support for ePrescribing initiatives.

The Web/cloud-based delivery mode is expected to be the fastest-growing segment of the market, driven by the increasing adoption of cloud-based healthcare solutions.

ePrescribing Market Product Insights Report Coverage & Deliverables

The report covers market size, market share, and growth for the following segments:

• Product: Solutions, Services, Delivery Mode
• Substances: Controlled substances, Non-controlled substances
• Usage: Handheld, Computer-based devices
• Specialties: Oncology, Neurology, Cardiology
• End-use: Hospital, Office-based physicians, Pharmacy

ePrescribing Market Analysis

The ePrescribing market size is expected to reach USD 10.2 billion by 2030. The market is growing rapidly due to increasing government initiatives, rising awareness about medication safety, and technological advancements.

ePrescribing Market Regional Insights

• North America: U.S., Canada
• Europe: Germany, UK, France, Spain, Italy, Rest of Europe
• Asia Pacific: China, Japan, India, Australia, Rest of Asia Pacific
• Latin America: Brazil, Mexico, Rest of Latin America
• Middle East and Africa: South Africa, Saudi Arabia, Rest of Middle East and Africa

Driving Forces: What's Propelling the ePrescribing Market

• Government initiatives
• Increased adoption of EHRs
• Rising awareness about medication safety
• Technological advancements

Challenges and Restraints in ePrescribing Market

• Regulatory compliance
• Product substitutes
• End-user resistance
• Data security concerns

Emerging Trends in ePrescribing Market

• Integration with EHRs and other healthcare systems
• Increasing use of ePrescribing for controlled substances
• Adoption of Web/cloud-based solutions

ePrescribing Industry News

• March 2022: FDB (First Databank, Inc.) introduced FDB Vela, a cloud-native e-prescribing network.
• October 2021: Allscripts Healthcare Solutions' Veradigm partnered with CareMetx, LLC to optimize specialty medication access and services.

Leading Players in the ePrescribing Market

• Allscripts Healthcare, LLC
• Athenahealth
• Change Healthcare
• DrFirst
• Epic Systems Corporation
• McKesson Corporation
• Networking Technology, Inc
• NXGN Management, LLC
• Practice Fusion, Inc.
• Surescripts

ePrescribing Market Segmentation

1. Product

• 1.1. Solutions
  • 1.1.1. Integrated solutions
  • 1.1.2. Standalone solutions
• 1.2. Services
  • 1.2.1. Support
  • 1.2.2. Implementation
  • 1.2.3. Training
  • 1.2.4. Network

2. Delivery Mode

• 2.1. Web/cloud-based
• 2.2. On-premises

3. Substances

• 3.1. Controlled substances
• 3.2. Non-controlled substances

4. Usage

• 4.1. Handheld
• 4.2. Computer-based devices

5. Specialties

• 5.1. Oncology
• 5.2. Sports medicine
• 5.3. Neurology
• 5.4. Cardiology
• 5.5. Other specialties

6. End-use

• 6.1. Hospital
• 6.2. Office-based physicians
• 6.3. Pharmacy
• 6.4. Other end-users

ePrescribing Market Segmentation By Geography

1. North America

• 1.1. U.S.
• 1.2. Canada

2. Europe

• 2.1. Germany
• 2.2. UK
• 2.3. France
• 2.4. Spain
• 2.5. Italy
• 2.6. Rest of Europe

3. Asia Pacific

• 3.1. China
• 3.2. Japan
• 3.3. India
• 3.4. Australia
• 3.5. Rest of Asia Pacific

4. Latin America

• 4.1. Brazil
• 4.2. Mexico
• 4.3. Rest of Latin America

5. Middle East and Africa

• 5.1. South Africa
• 5.2. Saudi Arabia
• 5.3. Rest of Middle East and Africa